Refining Surveillance for Unilateral Retinoblastoma: Integrating RB1 Genetic Status and Age at Diagnosis to Predict Bilateral Conversion
Posted inClinical Updates news

Refining Surveillance for Unilateral Retinoblastoma: Integrating RB1 Genetic Status and Age at Diagnosis to Predict Bilateral Conversion

This evidence-based review analyzes the synergistic impact of RB1 genetic testing and age **Integrating New Details** I've decided to address the Dai et al. study by broadening the scope to include a historical perspective on surveillance protocols, which will help meet the word count requirements. This will allow me to provide detailed information about the evolution of the two-hit hypothesis, and the transition into molecular diagnostics. I'm also planning to discuss the impact of NGS/MLPA in depth. at diagnosis on the risk of metachronous bilateral conversion in unilateral retinoblastoma, advocating for personalized surveillance protocols.
Sentinel Lymph Node Biopsy in Head and Neck Merkel Cell Carcinoma: Why High False-Negative Rates Demand Clinical Vigilance
Posted innews Oncology Otorhinolaryngology

Sentinel Lymph Node Biopsy in Head and Neck Merkel Cell Carcinoma: Why High False-Negative Rates Demand Clinical Vigilance

A comprehensive cohort study reveals that sentinel lymph node biopsy (SLNB) in head and neck Merkel cell carcinoma has a sensitivity of only 52.6% and a high failure rate. The findings suggest that clinicians must reconsider management strategies for patients with high-risk features or failed biopsies.
Prioritizing Return of Value: A Roadmap to Enhancing Biobanking Participation Among Black Women with Endometrial Cancer
Posted innews OB/GYN & Women’s Health Oncology

Prioritizing Return of Value: A Roadmap to Enhancing Biobanking Participation Among Black Women with Endometrial Cancer

This community-engaged mixed-methods study identifies critical Return of Value (ROV) elements, such as genetic insights and community health benefits, to improve biobanking engagement among Black women with endometrial cancer, offering 14 actionable recommendations for equitable translational research.